MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.2450
0.00 (0.00%)
At close: Sep 3, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 1.78 million as of September 4, 2026. Its market cap has decreased by -47.89% in one year.
Market Cap
1.78M
Enterprise Value
3.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 1.78M, a decrease of -97.76%. That is a compound annual growth rate of -68.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 1.78M | -70.23% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 5.01M |
| Restart Life Sciences | 4.69M |
| Innovotech | 4.36M |
| ASEP Medical Holdings | 3.97M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| Appili Therapeutics | 1.99M |
| Doseology Sciences | 1.60M |